Corteva is a crop protection pure play. The company was formed in 2019 when it was spun off from DowDuPont and spun off its seeds business, Vylor, in 2026. Corteva is a leader in the development of new crop protection products, including herbicides, insecticides, fungicides, biologicals, and plant health products. Corteva operates globally. North America generates nearly 40% of revenue while Latin America generates over 30%.
Last trade$8.84
Day change-$0.20 (-2.21%)
Day range$8.78 – $9.27
Volume12,167,152
Market cap$6.03B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$6.03B
Price / earnings
5.98×
Price / book
0.24×
Price / sales
0.34×
EV / sales
0.48×
EV / EBITDA
2.08×
Profitability
Earnings per share
$1.51
Return on assets
2.42%
Return on equity
4.01%
Dividend yield
8.02%
Liquidity and leverage
Debt / equity
0.19×
Current ratio
1.52×
Quick ratio
1.1×
Cash ratio
0.22×
Cash flow
Price / cash flow
4.98×
Price / free cash flow
9.59×
Free cash flow
$629M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for CTVA, quarterly periods
Line item
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Q3 FY2024 Sep 30, 2024
Revenue
$6.38B
$4.91B
$3.91B
$2.62B
$6.46B
$4.42B
$3.98B
$2.33B
Cost of revenue
$2.72B
$2.37B
$2.25B
$1.64B
$2.93B
$2.34B
$2.5B
$1.57B
Gross profit
$3.66B
$2.53B
$1.66B
$974M
$3.52B
$2.08B
$1.48B
$761M
Selling, general and administrative
$1.16B
$877M
$860M
$725M
$1.16B
$751M
$735M
$671M
Research and development
$388M
$341M
$413M
$351M
$375M
$335M
$365M
$348M
Total operating expenses
$1.87B
$1.52B
$1.48B
$1.28B
$1.77B
$1.27B
$1.35B
$1.22B
Operating income
$1.79B
$1.01B
$181M
-$301M
$1.75B
$805M
$129M
-$460M
Interest expense
-$47M
-$36M
-$46M
-$46M
-$52M
-$36M
-$60M
-$66M
Income before taxes
$1.63B
$858M
-$530M
-$370M
$1.8B
$784M
$88M
-$633M
Income taxes
$408M
$133M
$7M
-$62M
$422M
$117M
$138M
-$114M
Net income
$1.17B
$723M
-$549M
-$318M
$1.32B
$656M
-$39M
-$521M
Net income attributable to common shareholders
$1.16B
$720M
-$552M
-$320M
$1.31B
$652M
-$41M
-$524M
EBITDA
$2.18B
$1.4B
$502M
$29M
$2.13B
$1.12B
$520M
-$122M
Basic earnings per share
$1.73
$1.07
-$0.82
-$0.47
$1.92
$0.95
-$0.06
-$0.76
Diluted earnings per share
$1.73
$1.07
-$0.82
-$0.47
$1.92
$0.95
-$0.06
-$0.76
Recent news
Company coverage with links to the original publishers.
Archer-Daniels-Midland (ADM) reported Q3 adjusted EPS of $1.77, up 92% year-over-year and beating estimates by 8.6%, driven by stronger biofuels economics and improved operations. The company raised its 2026 EPS outlook to $5.50-$5.80 and targets $500-$750 million in cost savings over 3-5 years. However, analysts recommend a measured approach due to volatile commodity margins, trade policy risks, and uneven growth signals.
Mission Produce aims to double revenues to $4 billion and triple adjusted EBITDA to $450 million by fiscal 2035 through the Calavo acquisition, which is expected to generate over $30 million in annualized cost synergies. However, commodity price volatility, seasonal supply fluctuations, and margin pressures pose risks. Corteva and Dole face similar challenges with pricing pressures and rising costs despite pursuing innovation and expansion strategies.
Corteva reported Q3 2026 earnings that missed expectations with adjusted EPS of 6 cents versus 9 cents consensus and revenues of $1.52 billion versus $1.77 billion expected. The company significantly reduced full-year EBITDA guidance to $1.1-$1.13 billion from $1.3 billion due to severe conditions in Brazil, including $250 million in excess channel inventory, pricing pressure, and a 31% decline in Latin American organic sales. Management is implementing cost reduction initiatives and expects recovery in 2027 supported by inventory normalization and new product growth.
Corteva stock plummeted 20.2% after missing Q3 earnings expectations, reporting $0.06 per share instead of the anticipated $0.10, with sales below $1.6 billion versus expected $1.8 billion. The miss was driven by rapid price declines in agricultural chemicals, particularly in Latin America where sales fell 28% year-over-year. Management expects challenging market conditions ahead, especially in Brazil, though full-year guidance remains between $0.76-$0.80 per share on an adjusted basis—below Wall Street's GAAP expectations of $0.82.
Mission Produce (AVO) is focusing on operational efficiency and strategic integration following Q3 challenges marked by lower avocado prices and acquisition costs. The company expects Q4 improvement from higher Peruvian avocado sales, blueberry gains, and Calavo synergies, though pricing pressures and elevated debt remain concerns. Comparable agribusiness players Corteva and Dole are also pursuing strategic initiatives to strengthen profitability amid industry headwinds.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
Declared upcoming dividend$0.05 per share
Declared
Oct 22, 2026
Ex-dividend
Dec 1, 2026
Pay date
Dec 15, 2026
Ex-dividend
Amount / share
Pay date
Type
Sep 1, 2026
$0.18
Sep 15, 2026
recurring
Jun 1, 2026
$0.18
Jun 15, 2026
recurring
Mar 2, 2026
$0.18
Mar 16, 2026
recurring
Dec 1, 2025
$0.18
Dec 15, 2025
recurring
Sep 2, 2025
$0.18
Sep 15, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.